Physician profile
Jayesh M Madhani
NPI 1457461576
$1,734.42
in general payments reported to CMS, 2019-2025
18 companies · $502 in 2025
The $502 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.71 · 2020: $38.27 · 2021: $120 · 2022: $246 · 2023: $305 · 2024: $452 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $390.42 | 2020-2025 | Lifevest |
| Dexcom, INC. | $312.15 | 2023-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $266.89 | 2022-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $94.56 | 2019-2020 | |
| Novo Nordisk INC | $89.62 | 2024-2025 | Ozempic, Wegovy |
| Pfizer INC. | $84.49 | 2024 | |
| Novartis Pharmaceuticals Corporation | $75.62 | 2021-2023 | |
| Madrigal Pharmaceuticals | $72.30 | 2025 | Rezdiffra |
| E.R. Squibb & Sons, L.L.C. | $60.22 | 2023-2024 | Camzyos, Eliquis |
| Abiomed | $59.89 | 2024-2025 | Impella |
| Lilly USA, LLC | $41.44 | 2025 | Mounjaro, Zepbound |
| Amgen INC. | $40.52 | 2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.62 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $30.61 | 2024-2025 | Farxiga |
| Abbott Laboratories | $23.90 | 2025 | Cardiomems |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $20.33 | 2025 | Flexitouch Plus, Nimbl |
| Edwards Lifesciences Corporation | $19.64 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Exact Sciences Corporation | $13.20 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayesh Madhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.